Insider
Date
Role
Action
Shares
Price
Amount
Bryan T Vaughn
3 Nov 2026
EVP and President, Diagnostics
Sold on a plan
306
$353.70
$108.23K
Richelle P Parham
30 Oct 2026
Director
Sell
1,078
$361.22
$389.40K
Kerrii B Anderson
17 Aug 2026
Director
Sold on a plan
3,000
$318.02
$954.06K
Adam H Schechter
11 Aug 2026
President & CEO
Sold on a plan
4,669
$320.37
$1.50M
Amy B. Summy
4 Aug 2026
EVP, Chief Marketing Officer
Sell
924
$306.74
$283.43K
Peter J Wilkinson
3 Aug 2026
SVP, Chief Accounting Officer
Sold after exercise
1,338
$309.23
$413.75K
Peter J Wilkinson
3 Aug 2026
SVP, Chief Accounting Officer
Sold after exercise
82
$309.22
$25.36K
Bryan T Vaughn
2 Jul 2026
EVP and President, Diagnostics
Sold on a plan
234
$286.19
$66.97K
Kathryn W Kyle
2 Jul 2026
EVP, Chief Legal Officer
Sold on a plan
92
$286.19
$26.33K
Kathryn W Kyle
8 Jun 2026
EVP, Chief Legal Officer
Sold on a plan
762
$263.89
$201.08K
Adam H Schechter
11 May 2026
President & CEO
Sold on a plan
5,903
$254.50
$1.50M
Jonathan C Meltzer
27 Mar 2026
EVP, Operations
Sold on a plan
839
$267.05
$224.05K
Peter J Wilkinson
27 Mar 2026
SVP, Chief Accounting Officer
Sold on a plan
1,633
$267.05
$436.09K
Adam H Schechter
3 Mar 2026
President & CEO
Sell
8,705
$279.96
$2.44M
der Vaart Sandra D van
27 Feb 2026
EVP, Corporate Affairs
Sell
548
$284.91
$156.00K
Brian J Caveney
24 Feb 2026
EVP, Pres of ED, CMO & CSO
Sell
1,500
$286.31
$429.46K
Peter J Wilkinson
19 Feb 2026
SVP, Chief Accounting Officer
Sold on a plan
666
$277.94
$185.11K
Jonathan C Meltzer
12 Feb 2026
EVP, Operations
Sold on a plan
87
$290.42
$25.27K
Adam H Schechter
11 Feb 2026
President & CEO
Sold after exercise
5,273
$284.38
$1.50M
Jonathan C Meltzer
10 Feb 2026
EVP, Operations
Sold on a plan
91
$276.79
$25.19K
Jonathan C Meltzer
9 Feb 2026
EVP, Operations
Sold on a plan
88
$275.53
$24.25K
Adam H Schechter
11 Nov 2025
President & CEO
Sold on a plan
5,745
$262.75
$1.51M
Richelle P Parham
31 Oct 2025
Director
Sell
7,009
$254.28
$1.78M
der Vaart Sandra D van
13 Aug 2025
EVP, Chief Legal Officer
Sold after exercise
3,903
$271.42
$1.06M
Adam H Schechter
11 Aug 2025
President & CEO
Sold on a plan
5,643
$266.78
$1.51M
Dwight Gary Gilliland
30 Jul 2025
Director
Sell
2,000
$264.95
$529.90K
Peter J Wilkinson
29 Jul 2025
SVP, Chief Accounting Officer
Sell
100
$261.04
$26.10K
Peter J Wilkinson
29 Jul 2025
SVP, Chief Accounting Officer
Sell
102
$261.01
$26.62K
Kerrii B Anderson
24 Jul 2025
Director
Sold on a plan
3,500
$280.00
$980.00K
Kerrii B Anderson
24 Jul 2025
Director
Sold on a plan
3,500
$280.00
$980.00K
Kerrii B Anderson
1 Jul 2025
Director
Sold on a plan
500
$265.00
$132.50K
Kerrii B Anderson
11 Jun 2025
Director
Sell
500
$260.00
$130.00K
Brian J Caveney
3 Jun 2025
EVP, Pres of ED, CMO & CSO
Sell
2,000
$247.00
$494.00K
Adam H Schechter
12 May 2025
President & CEO
Sold on a plan
6,105
$248.73
$1.52M
Peter J Wilkinson
1 May 2025
SVP, Chief Accounting Officer
Sell
829
$242.27
$200.84K
der Vaart Sandra D van
1 May 2025
EVP, Chief Legal Officer
Sell
1,900
$238.36
$452.88K
Mark S Schroeder
28 Mar 2025
EVP, Pres Diagnostics & COO
Sold on a plan
2,635
$231.67
$610.45K
Amy B. Summy
28 Mar 2025
EVP, Chief Marketing Officer
Sold on a plan
758
$231.67
$175.61K
Kerrii B Anderson
5 Mar 2025
Director
Sell
500
$255.63
$127.82K
Mark S Schroeder
28 Feb 2025
EVP, Pres Diagnostics & COO
Sold after exercise
5,339
$249.23
$1.33M
der Vaart Sandra D van
25 Feb 2025
EVP, Chief Legal Officer
Sell
1,314
$251.30
$330.21K
Amy B. Summy
24 Feb 2025
EVP, Chief Marketing Officer
Sold on a plan
226
$250.40
$56.59K
Peter J Wilkinson
18 Feb 2025
SVP, Chief Accounting Officer
Sold after exercise
1,413
$246.10
$347.74K
Adam H Schechter
11 Feb 2025
President & CEO
Sold after exercise
6,121
$244.62
$1.50M
Kerrii B Anderson
7 Jan 2025
Director
Sold on a plan
1,000
$235.00
$235.00K
Dwight Gary Gilliland
2 Dec 2024
Director
Sell
1,000
$241.00
$241.00K
Glenn A Eisenberg
2 Dec 2024
Executive Vice President
Sold after exercise
11,711
$240.43
$2.82M
Amy B. Summy
22 Nov 2024
EVP, Chief Marketing Officer
Sold after exercise
3,672
$238.91
$877.14K
der Vaart Sandra D van
21 Nov 2024
EVP, Chief Legal Officer
Sell
1,000
$239.42
$239.42K
Adam H Schechter
11 Nov 2024
President & CEO
Sold on a plan
6,189
$243.47
$1.51M
Kerrii B Anderson
24 Oct 2024
Director
Sold on a plan
1,000
$230.00
$230.00K
der Vaart Sandra D van
19 Aug 2024
EVP, Chief Legal Officer
Sell
2,000
$227.05
$454.10K
Glenn A Eisenberg
15 Aug 2024
Chief Financial Officer, EVP
Sell
9,071
$224.55
$2.04M
Glenn A Eisenberg
15 Aug 2024
Chief Financial Officer, EVP
Sell
2,950
$223.62
$659.67K
Glenn A Eisenberg
15 Aug 2024
Chief Financial Officer, EVP
Sell
2,979
$222.65
$663.27K
Kerrii B Anderson
8 Aug 2024
Director
Sold on a plan
586
$225.00
$131.85K
Kerrii B Anderson
7 Aug 2024
Director
Sold on a plan
414
$225.00
$93.15K
Lance Berberian
5 Aug 2024
EVP, CIO & CTO
Sell
9,848
$228.95
$2.25M
Lance Berberian
5 Aug 2024
EVP, CIO & CTO
Sell
2,245
$229.79
$515.87K
der Vaart Sandra D van
14 May 2024
EVP, Chief Legal Officer
Sell
200
$210.84
$42.17K
der Vaart Sandra D van
14 May 2024
EVP, Chief Legal Officer
Sell
1,800
$210.83
$379.49K
Kerrii B Anderson
2 May 2024
Director
Sell
250
$200.10
$50.02K
Kerrii B Anderson
30 Apr 2024
Director
Sell
250
$204.14
$51.03K
Peter J Wilkinson
29 Apr 2024
SVP, Chief Accounting Officer
Sell
2,439
$204.33
$498.36K
Amy B. Summy
1 Apr 2024
EVP, Chief Marketing Officer
Sold on a plan
3,500
$217.29
$760.52K
Mark S Schroeder
1 Apr 2024
EVP, Pres Diagnostics & COO
Sold on a plan
6,477
$217.29
$1.41M
der Vaart Sandra D van
28 Mar 2024
EVP, Chief Legal Officer
Sold on a plan
3,553
$216.74
$770.08K
Amy B. Summy
7 Mar 2024
EVP, Chief Marketing Officer
Sold on a plan
227
$218.45
$49.59K
Mark S Schroeder
7 Mar 2024
EVP, Pres Diagnostics & COO
Sold after exercise
5,048
$218.45
$1.10M
Jonathan P. DiVincenzo
21 Feb 2024
EVP, Pres, Central Labs & Intl
Sell
500
$215.49
$107.75K
Glenn A Eisenberg
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
1,553
$217.98
$338.53K
Glenn A Eisenberg
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
6,665
$217.52
$1.45M
Glenn A Eisenberg
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
7,907
$215.68
$1.71M
Glenn A Eisenberg
21 Feb 2024
Chief Financial Officer, EVP
Sold after exercise
18,379
$215.37
$3.96M
der Vaart Sandra D van
13 Feb 2024
EVP, Chief Legal Officer
Sold on a plan
237
$226.45
$53.67K
der Vaart Sandra D van
8 Feb 2024
EVP, Chief Legal Officer
Sold on a plan
259
$222.06
$57.51K
der Vaart Sandra D van
5 Feb 2024
EVP, Chief Legal Officer
Sold on a plan
193
$220.57
$42.57K
Peter J Wilkinson
16 Nov 2023
SVP, Chief Accounting Officer
Sell
1,384
$210.71
$291.63K
Kerrii B Anderson
8 Aug 2023
Director
Sell
5,000
$211.57
$1.06M
der Vaart Sandra D van
29 Jun 2023
EVP, Chief Legal Officer
Sold on a plan
212
$240.00
$50.88K
Paul R Kirchgraber
19 May 2023
CEO, Covance Drug Development
Sold after exercise
4,300
$216.91
$932.71K
Mark S Schroeder
18 May 2023
EVP, Pres Diagnostics & COO
Sold after exercise
1,500
$216.77
$325.16K
Mark S Schroeder
31 Mar 2023
EVP, President-Diagnostics Lab
Sold on a plan
3,897
$225.81
$879.98K
Paul R Kirchgraber
21 Feb 2023
CEO, Covance Drug Development
Sold after exercise
8,000
$250.58
$2.00M
Mark S Schroeder
14 Feb 2023
EVP, President-Diagnostics Lab
Sell
309
$247.63
$76.52K
Mark S Schroeder
7 Feb 2023
EVP, President-Diagnostics Lab
Sell
409
$243.01
$99.39K
der Vaart Sandra D van
7 Feb 2023
EVP, Chief Legal Officer
Sell
219
$243.01
$53.22K
Mark S Schroeder
3 Feb 2023
EVP, President-Diagnostics Lab
Sell
324
$253.90
$82.26K
der Vaart Sandra D van
3 Feb 2023
EVP, Chief Legal Officer
Sell
173
$253.90
$43.92K
Mark S Schroeder
8 Nov 2022
EVP, President-Diagnostics Lab
Sell
1,116
$232.67
$259.66K
Glenn A Eisenberg
26 Sep 2022
Chief Financial Officer, EVP
Sell
2,830
$211.86
$599.57K
Glenn A Eisenberg
26 Sep 2022
Chief Financial Officer, EVP
Sell
11,699
$211.13
$2.47M
Glenn A Eisenberg
26 Sep 2022
Chief Financial Officer, EVP
Sell
4,844
$210.21
$1.02M
Glenn A Eisenberg
26 Sep 2022
Chief Financial Officer, EVP
Sell
5,627
$209.29
$1.18M
Brian J Caveney
7 Sep 2022
EVP, President of Diagnostics
Buy
44
$231.20
$10.25K
Glenn A Eisenberg
3 Aug 2022
Chief Financial Officer, EVP
Sold after exercise
1,500
$254.88
$382.32K
Glenn A Eisenberg
3 Aug 2022
Chief Financial Officer, EVP
Sold after exercise
19,338
$254.26
$4.92M
Glenn A Eisenberg
3 Aug 2022
Chief Financial Officer, EVP
Sold after exercise
11,262
$253.27
$2.85M
Peter J Wilkinson
1 Aug 2022
SVP, Chief Accounting Officer
Sold after exercise
10
$258.71
$2.59K
Peter J Wilkinson
1 Aug 2022
SVP, Chief Accounting Officer
Sold after exercise
757
$258.60
$195.76K
Peter J Wilkinson
1 Aug 2022
SVP, Chief Accounting Officer
Sold after exercise
1,809
$258.31
$467.29K
Brian J Caveney
7 Jun 2022
EVP, President of Diagnostics
Buy
42
$242.19
$10.17K
der Vaart Sandra D van
29 Mar 2022
EVP, Chief Legal Officer
Sell
2,449
$277.11
$678.64K
Mark S Schroeder
29 Mar 2022
EVP, President-Diagnostics Lab
Sell
2,356
$277.11
$652.87K
R Sanders Williams
25 Mar 2022
Director
Sell
572
$272.98
$156.14K
Amy B. Summy
10 Mar 2022
EVP, Chief Marketing Officer
Sell
249
$262.21
$65.29K
Peter M Neupert
16 Feb 2022
Director
Buy
600
$264.57
$158.74K
Peter M Neupert
16 Feb 2022
Director
Buy
1,600
$263.98
$422.37K
Peter M Neupert
16 Feb 2022
Director
Buy
1,300
$262.85
$341.71K
der Vaart Sandra D van
15 Feb 2022
EVP, Chief Legal Officer
Sell
207
$273.98
$56.71K
Mark S Schroeder
15 Feb 2022
EVP, President-Diagnostics Lab
Sell
207
$273.98
$56.71K
der Vaart Sandra D van
7 Feb 2022
EVP, Chief Legal Officer
Sell
218
$277.38
$60.47K
Mark S Schroeder
7 Feb 2022
EVP, President-Diagnostics Lab
Sell
204
$277.38
$56.59K
der Vaart Sandra D van
3 Feb 2022
EVP, Chief Legal Officer
Sell
172
$271.81
$46.75K
Mark S Schroeder
3 Feb 2022
EVP, President-Diagnostics Lab
Sell
161
$271.81
$43.76K
Dwight Gary Gilliland
15 Dec 2021
Director
Sell
18
$302.31
$5.44K
Dwight Gary Gilliland
15 Dec 2021
Director
Sell
25
$302.28
$7.56K
Dwight Gary Gilliland
15 Dec 2021
Director
Sell
100
$302.26
$30.23K
Dwight Gary Gilliland
15 Dec 2021
Director
Sell
357
$302.25
$107.90K
der Vaart Sandra D van
15 Sep 2021
EVP, Chief Legal Officer
Sold after exercise
4,500
$296.78
$1.34M
der Vaart Sandra D van
7 Jun 2021
EVP, Chief Legal Officer
Sold after exercise
4,500
$266.56
$1.20M
Paul R Kirchgraber
6 May 2021
CEO, Covance Drug Development
Sell
2,500
$276.55
$691.38K
Jean-Luc Belingard
3 May 2021
Director
Sold after exercise
2,600
$269.16
$699.80K
der Vaart Sandra D van
30 Mar 2021
EVP, Chief Legal Officer
Sell
812
$251.88
$204.53K
Mark S Schroeder
30 Mar 2021
EVP, President-Diagnostics Lab
Sell
667
$251.88
$168.00K
Peter J Wilkinson
18 Feb 2021
SVP, Chief Accounting Officer
Sold after exercise
2,317
$241.51
$559.59K
Mark S Schroeder
16 Feb 2021
EVP, President-Diagnostics Lab
Sell
85
$237.06
$20.15K
Mark S Schroeder
16 Feb 2021
EVP, President-Diagnostics Lab
Sell
103
$237.06
$24.42K
der Vaart Sandra D van
16 Feb 2021
EVP, Chief Legal Officer
Sell
100
$236.05
$23.61K
der Vaart Sandra D van
16 Feb 2021
EVP, Chief Legal Officer
Sell
5
$235.89
$1.18K
der Vaart Sandra D van
16 Feb 2021
EVP, Chief Legal Officer
Sell
103
$237.06
$24.42K
Mark S Schroeder
5 Feb 2021
EVP, President-Diagnostics Lab
Sell
203
$225.85
$45.85K
der Vaart Sandra D van
5 Feb 2021
EVP, Chief Legal Officer
Sell
109
$225.85
$24.62K
R Sanders Williams
26 Jan 2021
Director
Exercised, kept
1,300
$98.49
$128.04K
Mark S Schroeder
6 Nov 2020
EVP, President-Diagnostics Lab
Sell
588
$214.59
$126.18K
Paul R Kirchgraber
4 Nov 2020
CEO, Covance Drug Development
Sell
1,500
$214.14
$321.20K
R Sanders Williams
8 Jul 2020
Director
Sold after exercise
1,300
$173.12
$225.06K
der Vaart Sandra D van
2 Jul 2020
EVP, Chief Legal Officer
Sell
435
$170.00
$73.95K
der Vaart Sandra D van
24 Jun 2020
EVP, Chief Legal Officer
Sell
436
$160.33
$69.90K
der Vaart Sandra D van
24 Jun 2020
EVP, Chief Legal Officer
Sell
436
$160.33
$69.90K
David P King
5 May 2020
Director
Sell
31,250
$160.00
$5.00M
Judith C Seltz
10 Mar 2020
EVP, CHRO
Buy
330
$168.56
$55.62K
Judith C Seltz
28 Feb 2020
EVP, CHRO
Buy
250
$174.94
$43.74K
Peter J Wilkinson
21 Feb 2020
SVP, Chief Accounting Officer
Sell
297
$189.65
$56.33K
Jean-Luc Belingard
19 Feb 2020
Director
Sold after exercise
26,479
$189.76
$5.02M
R Sanders Williams
13 Feb 2020
Director
Sell
1,227
$188.49
$231.28K
Mark S Schroeder
13 Feb 2020
EVP, President-Diagnostics Lab
Sell
103
$188.49
$19.41K
Mark S Schroeder
13 Feb 2020
EVP, President-Diagnostics Lab
Sell
85
$188.49
$16.02K
der Vaart Sandra D van
13 Feb 2020
SVP, Global General Counsel
Sell
103
$188.49
$19.41K
der Vaart Sandra D van
13 Feb 2020
SVP, Global General Counsel
Sell
105
$188.49
$19.79K
der Vaart Sandra D van
10 Feb 2020
SVP, Global General Counsel
Sell
133
$181.99
$24.20K
Mark S Schroeder
10 Feb 2020
EVP, President-Diagnostics Lab
Sell
108
$181.99
$19.65K
David P King
28 Oct 2019
President & CEO
Sell
12,352
$166.21
$2.05M
David P King
28 Oct 2019
President & CEO
Sell
10,391
$165.32
$1.72M
David P King
28 Oct 2019
President & CEO
Sell
7,434
$164.16
$1.22M
Kerrii B Anderson
23 Sep 2019
Director
Sold after exercise
2,600
$171.85
$446.81K
Lisa J Uthgenannt
4 Sep 2019
Chief Human Resources Officer
Sold after exercise
2,466
$168.59
$415.74K
Lance Berberian
30 Aug 2019
SVP, Chief Information Officer
Sell
5,902
$169.80
$1.00M
R Sanders Williams
5 Aug 2019
Director
Sell
500
$162.91
$81.46K
der Vaart Sandra D van
8 Jul 2019
SVP, Global General Counsel
Sell
2,328
$176.75
$411.47K
Glenn A Eisenberg
8 Jul 2019
Chief Financial Officer, EVP
Sell
5,563
$176.75
$983.26K
Kerrii B Anderson
20 Jun 2019
Director
Sold after exercise
3,100
$170.00
$527.00K
Glenn A Eisenberg
7 Jun 2019
Chief Financial Officer, EVP
Sell
1,294
$168.41
$217.92K
Glenn A Eisenberg
7 Jun 2019
Chief Financial Officer, EVP
Sell
4,450
$167.65
$746.05K
Glenn A Eisenberg
7 Jun 2019
Chief Financial Officer, EVP
Sell
4,256
$166.82
$710.00K
R Sanders Williams
6 May 2019
Director
Sell
500
$162.20
$81.10K
Robert E Mittelstaedt Jr
3 May 2019
Director
Sold after exercise
3,700
$166.30
$615.31K
Lisa J Uthgenannt
2 May 2019
Chief Human Resources Officer
Sell
4,000
$164.00
$656.00K
R Sanders Williams
13 Feb 2019
Director
Sell
1,038
$147.00
$152.59K
Jean-Luc Belingard
12 Feb 2019
Director
Sold after exercise
3,700
$146.06
$540.41K
R Sanders Williams
27 Nov 2018
Director
Sell
350
$162.14
$56.75K
Kerrii B Anderson
5 Nov 2018
Director
Sold after exercise
3,700
$163.29
$604.16K
Edward T Dodson
6 Jun 2018
Principal Accounting Officer
Sold after exercise
13,000
$183.35
$2.38M
Lisa J Uthgenannt
4 Jun 2018
Chief Human Resources Officer
Sell
4,500
$182.10
$819.45K
Lance Berberian
31 May 2018
SVP, Chief Information Officer
Sell
315
$182.37
$57.45K
Lance Berberian
31 May 2018
SVP, Chief Information Officer
Sell
5,185
$182.30
$945.23K
Dwight Gary Gilliland
31 May 2018
Director
Sell
400
$181.30
$72.52K
Dwight Gary Gilliland
31 May 2018
Director
Sell
300
$181.29
$54.39K
Dwight Gary Gilliland
31 May 2018
Director
Sell
436
$181.29
$79.04K
Dwight Gary Gilliland
31 May 2018
Director
Sell
127
$181.26
$23.02K
Glenn A Eisenberg
30 May 2018
Chief Financial Officer, EVP
Sell
3,280
$181.50
$595.32K
Glenn A Eisenberg
30 May 2018
Chief Financial Officer, EVP
Sell
6,720
$181.06
$1.22M
M. Huff Gary
30 May 2018
CEO, LabCorp Diagnostics
Sell
1,610
$182.50
$293.82K
David P King
23 May 2018
President & CEO
Sold after exercise
5,400
$176.13
$951.09K
David P King
23 May 2018
President & CEO
Sold after exercise
44,566
$175.27
$7.81M
David P King
23 Apr 2018
President & CEO
Sold after exercise
21,200
$166.37
$3.53M
David P King
23 Apr 2018
President & CEO
Sold after exercise
28,767
$165.94
$4.77M
David P King
23 Mar 2018
President & CEO
Sold after exercise
1,700
$166.38
$282.84K
David P King
23 Mar 2018
President & CEO
Sold after exercise
10,313
$165.39
$1.71M
David P King
23 Mar 2018
President & CEO
Sold after exercise
36,265
$164.55
$5.97M
David P King
23 Mar 2018
President & CEO
Sold after exercise
1,689
$163.58
$276.29K
Glenn A Eisenberg
12 Feb 2018
Chief Financial Officer, EVP
Sell
500
$168.61
$84.31K
Glenn A Eisenberg
12 Feb 2018
Chief Financial Officer, EVP
Sell
1,600
$167.78
$268.44K
Glenn A Eisenberg
12 Feb 2018
Chief Financial Officer, EVP
Sell
6,300
$167.16
$1.05M
Kerrii B Anderson
9 Feb 2018
Director
Sold after exercise
3,300
$166.10
$548.12K
Adam H Schechter
8 Feb 2018
Director
Sell
1,263
$169.29
$213.81K
Dwight Gary Gilliland
30 Oct 2017
Director
Sell
971
$153.52
$149.07K
David P King
6 Sep 2017
President & CEO
Sold after exercise
7,500
$157.34
$1.18M
David P King
6 Sep 2017
President & CEO
Sold after exercise
37,187
$156.77
$5.83M
David P King
5 Sep 2017
President & CEO
Sold after exercise
132,713
$157.06
$20.84M
F Samuel Eberts III
25 Aug 2017
Chief Legal Officer, Secretary
Sold after exercise
31,500
$155.22
$4.89M
R Sanders Williams
11 Aug 2017
Director
Sold after exercise
11
$156.92
$1.73K
R Sanders Williams
11 Aug 2017
Director
Sold after exercise
8
$156.91
$1.26K
R Sanders Williams
11 Aug 2017
Director
Sold after exercise
2,881
$156.90
$452.02K
R Sanders Williams
11 Aug 2017
Director
Sold after exercise
200
$156.68
$31.34K
Glenn A Eisenberg
1 Aug 2017
Chief Financial Officer, EVP
Sell
5,968
$159.46
$951.67K
Lisa J Uthgenannt
1 Aug 2017
Chief Human Resources Officer
Sell
5,000
$160.00
$800.00K
Edward T Dodson
1 Aug 2017
Principal Accounting Officer
Sell
2,671
$160.13
$427.71K
Edward T Dodson
1 Aug 2017
Principal Accounting Officer
Sell
200
$160.13
$32.03K
Lance Berberian
22 May 2017
SVP, Chief Information Officer
Sell
3,613
$139.84
$505.26K
Jean-Luc Belingard
9 May 2017
Director
Sold after exercise
992
$142.19
$141.05K
Glenn A Eisenberg
9 Mar 2017
Chief Financial Officer, EVP
Sell
2,200
$142.47
$313.44K
Glenn A Eisenberg
9 Mar 2017
Chief Financial Officer, EVP
Sell
100
$142.46
$14.25K
Kerrii B Anderson
24 Feb 2017
Director
Exercised, kept
1,000
$75.63
$75.63K
Robert E Mittelstaedt Jr
24 Feb 2017
Director
Sold after exercise
367
$142.72
$52.38K
Robert E Mittelstaedt Jr
24 Feb 2017
Director
Sold after exercise
100
$142.70
$14.27K
Robert E Mittelstaedt Jr
24 Feb 2017
Director
Sold after exercise
2,000
$142.69
$285.38K
Robert E Mittelstaedt Jr
24 Feb 2017
Director
Sold after exercise
2,633
$142.69
$375.69K
Robert E Mittelstaedt Jr
24 Feb 2017
Director
Sold after exercise
200
$142.68
$28.54K
Kerrii B Anderson
23 Feb 2017
Director
Sold after exercise
1,000
$140.00
$140.00K
Kerrii B Anderson
23 Feb 2017
Director
Sold after exercise
992
$140.00
$138.88K
